New Pfizer storage guidance could help rural Covid vaccine rollout

Sally Whyte
Updated May 26 2021 - 5:53pm, first published 10:30am
The Pfizer vaccine is expected to become the main vaccine to be used for people aged under 50 in Australia. Picture: Shutterstock
The Pfizer vaccine is expected to become the main vaccine to be used for people aged under 50 in Australia. Picture: Shutterstock

The Therapeutic Goods Administration has changed its storage conditions for the Pfizer vaccine, allowing the breakthrough vaccine to be stored longer at normal refrigeration temperatures, a move which could have a big impact on Australia's sluggish vaccine rollout.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options
Sally Whyte

Sally Whyte

Federal Politics Reporter

I report on a range of issues in federal politics and the public service, with a real passion for how decisions made in Canberra affect the lives of Australians.

Get the latest Canberra news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.